Today: 22 June 2026
Browse Category

NASDAQ:PRVA 20 April 2026

Hims & Hers Surges Ahead of Earnings as Omnicell Lags in Healthcare Tech Shakeout

Hims & Hers Surges Ahead of Earnings as Omnicell Lags in Healthcare Tech Shakeout

Hims & Hers Health shares jumped 8.9% Monday morning, extending a 48.3% weekly gain ahead of its May 11 earnings report. The FDA will meet in July to consider rules on compounding peptides, a market Hims entered last year. Hims ended 2025 with 2.511 million subscribers and $617.8 million in fourth-quarter revenue, up 28%. Omnicell reported $314 million in fourth-quarter revenue and a $2 million net loss.
20 April 2026
····

Stock Market Today

  • Cettire Share Price Slumps as Regal Funds Management Cuts Stake
    June 22, 2026, 3:21 AM EDT. Regal Funds Management has reduced its stake in online luxury retailer Cettire, selling 10.6 million shares between June 12 and 17. This move lowers the hedge fund's holding from 15.3% to 11.45%, reflecting a significant loss amid Cettire's declining market value. Once part of the S&P/ASX 300 index, Cettire has seen its market capitalisation slide, prompting Regal to crystallise tens of millions of dollars in losses. The share sales highlight challenges faced by the online luxury goods sector, with investors adjusting positions in response to shifting market conditions.

Latest articles

Cognizant (NASDAQ: CTSH) Slides 10% as Nasdaq-100 Exit Nears

Cognizant (NASDAQ: CTSH) Slides 10% as Nasdaq-100 Exit Nears

22 June 2026
Cognizant shares plunged 10.49% to $43.70, erasing $2.4 billion in equity value—more than its $2 billion 2026 buyback target—after Accenture’s narrowed growth outlook, a Berenberg downgrade, and looming Nasdaq-100 removal, even as S&P 500 and Nasdaq rallied; investors now eye Q2 guidance as the next key test.
Pentagon Could Outpace Tech Giants on Small Nuclear Projects

Pentagon Could Outpace Tech Giants on Small Nuclear Projects

22 June 2026
Valar Atomics’ Ward 250 became the first DOE-authorized advanced reactor built outside a national lab to achieve criticality, signaling a shift as U.S. defense demand accelerates small nuclear deployment, with the Army allocating over $2 billion for microreactors—moving the sector from policy to production and raising near-term demand expectations.
Go toTop